The Peter Attia Drive

The Peter Attia Drive

#384 - Special episode — Obicetrapib: The CETP inhibitor with cardiovascular benefits and potential Alzheimer's prevention

Mar 16, 2026 · 52:40

Listen to Episode

✨ AI Summary

Obicetrapib is a CETP inhibitor with cardiovascular benefits.
Explores history of failed CETP inhibitors and their dramatic failures.
Discusses trials on cardiovascular risk, LDL, and Lp(a) impact.

Guests on This Episode

SE

Special episode

2 podcast appearances

More from The Peter Attia Drive

#385 - AMA #82: Applying the tools of longevity in the real world: disease prevention, DEXA scans, artificial sweeteners, injury recovery, stability training, habit formation, protein intake and mTOR activation, and more

Mar 23, 2026 · 18:52

#381 ‒ Alzheimer's disease in women: how hormonal transitions impact the female brain, the role of HRT, genetics, and lifestyle on risk, and emerging diagnostics and therapies | Lisa Mosconi, Ph.D.

Jan 26, 2026 · 02:06:34

#380 ‒ The seed oil debate: are they uniquely harmful relative to other dietary fats? | Layne Norton, Ph.D.

Jan 19, 2026 · 02:07:42

#379 - AMA #79: A guide to cardiorespiratory training at any fitness level to improve healthspan, lifespan, and long-term independence

Jan 12, 2026 · 38:36

View all episodes →